GYGokhan Yalciner

Gokhan Yalciner

*This is an algorithmically generated author record based on publicly available information.

Gokhan Yalciner has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Perioperative D-dimer levels and head and neck cancer surgery: a prospective observational study

    by Başak Yalçıner, Özge Nur Koçak, Gökhan Yalçıner, Onur Büyükkoç, Burak Çelik, Ceylan Bal, Mehmet Ali Babademez

    Objectives: D-dimer molecules are formed as a result of fibrinolysis and elevation of D-dimer levels are suggestive for thrombosis. The elevation of D-dimer levels and its correspondence with thromboembolism in orthopedic and general surgeries are well studied, but there are only a few studies in literature that investigates this issue in head and neck surgery. We aimed to investigate D-dimer levels and its course throughout the perioperative period in patients who underwent head and neck cancer surgery. Methods: We conducted a prospective, observational study in patients who underwent neck dissection along with primary tumor resection in our otorhinolaryngology clinic between January 2022 and June 2023. D-dimer levels were measured from blood samples preoperatively and postoperatively days 0–7 and on postoperative 14th day. D-dimer levels were compared statistically. Results: Twenty-one patients were included in the study. D-dimer values peaked on the first day then gradually decreased and reached a level slightly below 2 times of the preoperative values on the 14th day. The change in D-dimer levels between preoperative and postoperative days 1–14 was statistically significant. The difference between D-dimer levels measured on each day of the first week and levels on 14th day was found to be significant. Also, difference of D-Dimer levels between postoperative day 0 and day 7 was statistically significant. Conclusions: The trend of D-dimer levels following surgery in head and neck cancer patients may prove useful in clinical practice to rule out thrombotic events, in accordance with other risk factors and symptomatology.

  • Consequences of FFP3 mask usage on venous blood gases

    by Gokhan Yalciner, Mehmet Ali Babademez, Fatih Gul, Serkan Serifler, Kadir Sinasi Bulut, Levent Ozturk

    Objectives/hypothesis To investigate the effect of FFP3 mask usage on venous blood gases (VBG) and some subjective symptoms Methods VBG analyses and subjective symptom questionary were obtained from 15 healthcare proffesionals before and after 4-h FFP3 mask usage. Results Wearing an FFP3 mask for 4 hours did not change any venous blood gas parameters between pre- and post-values, statistically. According to an 8-symptom questionary, only nausea did not show any significance. Headache, lightheadedness, visual difficulties, shortness of breath, palpitation, confusion, and difficult communication showed statistically significant difference between pre and post values. Conclusion Four-hour use of FFP3 mask did not cause any significant VBG change. Although the participants complained about some subjective symptoms, this study indicated that long-term use of FFP3 mask did not cause any significant discomforts, and it was well tolerated.


  • Thiol‐disulfide as a novel indicator of obstructive sleep apnea

    by Emine Argüder, Ebru Şengül Parlak, Hatice Kılıç, Habibe Hezer, Salim Neşelioğlu, Hatice Canan Hasanoğlu, Gökhan Yalçıner, Mehmet Ali Babademez, Özcan Erel

    Introduction: Obstructive sleep apnea (OSA) is an oxidative stress disease, which has been considered to be a notable risk and associated with increased cardiovascular morbidity and mortality. Thiol‐disulfide homeostasis is as a novel indicator of oxidative stress.Objectives: We aimed to evaluate thiol‐disulfide homeostasis in a large patient population with OSA.Methods: A total of 230 with OSA and 40 healthy controls were included in the study. Inclusion criteria for OSA patients are having apnoea‐hypopnoea index of ≥5/hour, being more than 18 years of age and having no previous treatment for OSA. Thiol‐disulfide analysis was done for the patients and control group. Blood thiol‐disulfide homeostasis was analysed using the new automatic method, developed by Erel and Neşelioğlu.Results: Among all OSA subjects, 149 (64.8%) were males and the mean ages of the patients were 53.38 ± 10.22. Total thiol, native thiol (SH) and disulfide (SS) levels were significantly lower in OSA group compared to the control group (P < .001, P < .001 and P = .039 respectively). Also, total thiol and native thiol (SH) were significantly different between the groups according to OSA severity (mild‐moderate to severe OSA) (P < .001 and P < .001 respectively). Thiol‐disulfide redox parameters were correlated with apnoea‐hypopnoea index (AHI) scores.Conclusion: The present prospective study showed that thiol/disulfide homeostasis was unbalanced in OSA patients. Especially, in OSA patients have low level of thiol/disulfide redox parameters when compared to healthy subjects. Evaluating thiol‐disulfide homeostasis in OSA may be a contributing aspect to assessment and monitoring of the patient.


  • Open Access

    Debulking obstructing laryngeal cancers to avoid tracheotomy

    by Fatih Gul, Yagmur Canan Teleke, Gokhan Yalciner, Mehmet Ali Babademez


  • A novel method for evaluation of oxidative stress in children with OSA

    by Fatih Gul, Togay Muderris, Gokhan Yalciner, Halil Ibrahim Mise, Yagmur Canan, Mehmet Ali Babademez, Ozcan Erel